REQUEST A DEMO
Total
USD $0.00
Search more companies

Vertex Pharmaceuticals (Czech Republic) S.R.O. (Czech Republic)

Main Activities: Advertising Agencies
Full name: Vertex Pharmaceuticals (Czech Republic) S.R.O. Profile Updated: November 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Vertex Pharmaceuticals (Czech Republic) S.R.O. is a company based in Czech Republic, with its head office in Prague. It operates in the Advertising Agencies industry. The enterprise was incorporated on June 07, 2018. The total number of employees is currently 1 - 5 (2023).

Headquarters
Plzenska 3350/18
Prague; The City of Prague; Postal Code: 15000

Contact Details: Purchase the Vertex Pharmaceuticals (Czech Republic) S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Vertex Pharmaceuticals (Czech Republic) S.R.O. report to view the information.
Outstanding Shares:
Purchase the Vertex Pharmaceuticals (Czech Republic) S.R.O. report to view the information.
Registered Capital:
Purchase the Vertex Pharmaceuticals (Czech Republic) S.R.O. report to view the information.
Incorporation Date:
June 07, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Vertex Pharmaceuticals (Czech Republic) S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total operating revenue
33.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?